SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Concise Analysis of the International Biopharmaceuticals Market

[January 31, 2014]

Research and Markets: Concise Analysis of the International Biopharmaceuticals Market

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/9rtb65/biopharmaceuticals) has announced the addition of the "Biopharmaceuticals - A Global Market Overview" report to their offering.

The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies as also generic drug manufacturers, who are also engaged in developing biosimilars.

In conjunction with the traditional small biopharmaceutical companies, the new bigger entrants have been focused on continually expanding the global biologics pipeline, implying that the number and proportion of new pharmaceuticals being commercialized would increasingly comprise biopharmaceuticals and not small molecule drugs. As the cost of developing biopharmaceuticals and bringing them to market is generally much higher, offering enhanced profit margins, it comes as no surprise tat the global pharmaceutical industry would continue to rely on biopharmaceuticals for profits and innovation, in addition to its very survival.


Even though the worldwide economic recession has been slow in recovering, the global pharmaceutical and biopharmaceutical industries have marched ahead, showing profitability and growth. According to estimates, more than 10k therapeutics are currently in the research and development stage, which include chemical substance pharmaceuticals or drugs and biotechnology-derived pharmaceuticals or biopharmaceuticals undergoing over 40k clinical trials.

Key Topics Covered:

Part A: Global Market Perspective

1. Introduction

2. Key Facts And Figures Of Biopharma Industry And Latest Approvals

3. Key Market Trends

4. Key Global Players

5. Key Business Trends

6. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. North America

2. Europe

3. Asia-Pacific

4. South America

5. Rest Of World

Part C: Guide To The Industry

1. North America

2. Europe

3. Asia-Pacific

4. Rest Of World

Part D: Annexure

1. Research Methodology

2. The Questionnaire

3. Feedback

Companies Mentioned:

  • Abbott Laboratories
  • Amgen
  • Astrazeneca
  • BASF
  • Bayer
  • Biocon
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Eli Lilly and Company
  • Genentech
  • Glaxosmithkline
  • Hospira
  • Johnson & Johnson
  • LG Life Sciences
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Ranbaxy Laboratories
  • Roche Holding
  • Sanofi
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries
  • UCB

For more information visit http://www.researchandmarkets.com/research/9rtb65/biopharmaceuticals


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy